Skip to content

GENB - Generate Biomedicines, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchG

Generate Biomedicines, Inc. Common Stock

GENB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

G

GENBGenerate Biomedicines, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $18.18
52-wk low: $11.00
Prev close: $14.95
Mkt cap: $2.18B
P/S: 82.3x
P/B: 4.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$176.6M

CW
Cathie Wood
Q2 2026 13F
$21.7M
position
EP
ExodusPoint
Michael Gelband · Q1 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 8.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $2.2B

Valuation

P/S82.25
P/B4.53

Quality

Operating margin-1134.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: GENB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $2.18B

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

-1134.0%

ROE

-81.7%

$3.9M

position

DS

D.E. Shaw

Q1 2026 13F

$1.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for GENB

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.52-8.3%

-$0.48 expected

Next report

What the street expects next

-81.7%

ROA-34.6%

Growth